Filters
Hikma delivers strong 2023 performance and a positive outlook for 2024
Press Release, Financial Results
Hikma hosts White House Drug Policy Director Dr. Rahul Gupta at its Columbus, Ohio manufacturing facility
Press Release, Corporate
Hikma launches Fentanyl Citrate Injection, USP, in a prefilled syringe in the US
Press Release, Product
Hikma launches Alvimopan Capsules in the US
Press Release, Product
Hikma expands its agreement with AFT Pharmaceuticals for the commercialisation of injectable pain medication Combogesic®...
Press Release, Business Development
Hikma announces US launch of COMBOGESIC® IV
Press Release, Product
Hikma appoints Julie Hill, as Senior Vice President, Corporate Quality Compliance/Health and Safety
Press Release, Leadership
Hikma Announces Agreement in Principle for Nationwide US Opioid Settlement Framework
Press Release, Corporate
Activ Surgical, a Hikma Ventures portfolio company, completes the first international procedure using ActivSight™ Intell...
Press Release, Corporate
Hikma and Guardant Health sign exclusive partnership agreement to bring transformative cancer diagnostic technology to t...
Press Release, Business Development
Hikma to present at 42nd Annual J.P. Morgan Healthcare Conference
Press Release, Corporate
Hikma launches Phenylephrine HCl Injection, USP, in ready-to-use vials in the US
Press Release, Product
Hikma continues strong momentum across the Group and upgrades guidance for 2023
Press Release, Financial Results